6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform
Financial Results, Press Release
Material disclosure
Announces First Quarter 2026 Financial Results
Annual Report to Security Holders
Dr. Kevin Haas Appointed Chief Development and Technology Officer
Announces Fourth Quarter and Full Year 2025 Financial Results
Announces Preliminary Fourth Quarter and Full-Year 2025 Results
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus Filed Pursuant to Rule 425
Additional Proxy Materials
Definitive Proxy Statement
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership